Nature: Testing for antibodies to cyclic citrullinated peptides and rheumatoid factor—what is best for early RA?
Testing for antibodies to cyclic citrullinated peptides and rheumatoid factor—what is best for early RA?
Please provide your email address to receive an email when new articles are posted on . Among patients who are cyclic citrullinated peptide antibody positive, the risk for rheumatoid arthritis ...
People who have a specific genetic variant of the PTPN22 gene and test positive for antibodies against cyclic citrullinated peptide are much more at risk of developing rheumatoid arthritis than people ...
Birmingham, UK - Patients with newly developed joint inflammation who have both rheumatoid factor (RF) and antibodies to cyclic citrullinated peptide (anti-CCP) are at high risk for progression to ...
Ann Arbor, MI - Antibodies against cyclic citrullinated peptide (CCP) have already proved useful in helping to establish the diagnosis of rheumatoid arthritis (RA) and in helping to predict its ...
Smoking has previously been shown to be associated with rheumatoid factor (RF)-positive rheumatoid arthritis (RA). A European study found an association between smoking, anti-cyclic citrullinated ...
The potential of cyclic peptides in drug discovery has become increasingly apparent in recent years. Their cyclic structure imbues them with enhanced target affinity, metabolic stability and a ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — Among patients with rheumatoid arthritis, the presence of serum anti-citrullinated protein antibodies ...
Nature: The B cell response to citrullinated antigens in the development of rheumatoid arthritis
The anti-citrullinated protein antibody (ACPA) response dynamically evolves before the onset of rheumatoid arthritis (RA) HLA-shared epitope alleles and T cells are suggested to be involved in driving ...